These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2952771)
1. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms. Norman AB; Battaglia G; Creese I J Neurosci; 1987 May; 7(5):1484-91. PubMed ID: 2952771 [TBL] [Abstract][Full Text] [Related]
2. Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment. Battaglia G; Norman AB; Creese I J Pharmacol Exp Ther; 1987 Oct; 243(1):69-75. PubMed ID: 2889827 [TBL] [Abstract][Full Text] [Related]
4. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade. Henry JM; Roth GS Life Sci; 1984 Aug; 35(8):899-904. PubMed ID: 6482680 [TBL] [Abstract][Full Text] [Related]
5. Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation. Battaglia G; Norman AB; Creese I Eur J Pharmacol; 1988 Jan; 145(3):281-90. PubMed ID: 2895004 [TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor turnover rates in rat striatum are age-dependent. Leff SE; Gariano R; Creese I Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3910-4. PubMed ID: 6587399 [TBL] [Abstract][Full Text] [Related]
7. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats. Ekman A; Eriksson E Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955 [TBL] [Abstract][Full Text] [Related]
8. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study. Morissette M; Lévesque D; Di Paolo T Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544 [TBL] [Abstract][Full Text] [Related]
9. Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade. Traub M; Reches A; Wagner HR; Fahn S Neurosci Lett; 1986 Oct; 70(2):245-9. PubMed ID: 2946007 [TBL] [Abstract][Full Text] [Related]
10. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ. Crawford CA; Rowlett JK; McDougall SA; Bardo MT Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063 [TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors. Hess EJ; Norman AB; Creese I J Neurosci; 1988 Jul; 8(7):2361-70. PubMed ID: 2907912 [TBL] [Abstract][Full Text] [Related]
12. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Giorgi O; Biggio G Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234 [TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats. Lévesque D; Di Paolo T Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586 [TBL] [Abstract][Full Text] [Related]
14. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats. Henry JM; Joseph JA; Kochman K; Roth GS Brain Res; 1987 Aug; 418(2):334-42. PubMed ID: 2960421 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states. George SR; Watanabe M; Seeman P J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204 [TBL] [Abstract][Full Text] [Related]
16. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro. Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587 [TBL] [Abstract][Full Text] [Related]
17. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain. Xu SX; Hatada Y; Black LE; Creese I; Sibley DR J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530 [TBL] [Abstract][Full Text] [Related]
18. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631 [TBL] [Abstract][Full Text] [Related]
19. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment. MacKenzie RG; Zigmond MJ J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330 [TBL] [Abstract][Full Text] [Related]
20. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum. Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]